Skip to main content
Clinical Trials/NCT01457066
NCT01457066
Completed
Phase 1

Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM

University of California, Los Angeles1 site in 1 country118 target enrollmentDecember 2012
ConditionsHIV

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
HIV
Sponsor
University of California, Los Angeles
Enrollment
118
Locations
1
Primary Endpoint
Retention in care
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The goal of this proposal is to culturally adapt and tailor an existing, theory-based intervention, using state-of-the-art methods designed to maximize cultural sensitivity, feasibility and acceptability to HIV+ Latino MSM, and to test it in a small randomized controlled trial (n=60 intervention; n=60 control).

Detailed Description

While early receipt of and adherence to antiretroviral therapy are critical for effective HIV treatment, engagement with and retention in HIV care are essential first steps. Retention in HIV care is particularly important for traditionally disadvantaged groups, such as Latino MSMs, who are over-represented in the HIV epidemic. HIV+ Latino MSM therefore urgently need interventions to improve their retention in HIV care, which may be affected by a number of culture-specific factors. The goal of this proposal is to culturally adapt and tailor an existing, theory-based intervention, using state-of-the-art methods designed to maximize cultural sensitivity, feasibility and acceptability to HIV+ Latino MSM, and to test it in a small randomized controlled trial (n=60 intervention; n=60 control). The study will be conducted among insufficiently retained HIV+ Latino MSM at AltaMed, the largest provider of HIV medical services for Latinos in Los Angeles. The proposed intervention is designed to retain participants in HIV care by addressing barriers to and facilitators of HIV care salient to Latinos, using group-based as well as one-on-one, peer-based learning approaches.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
September 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

William Cunningham

Prinicipal Investigator

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retention in care

Time Frame: Six month follow up

Retention in care will be assessed through the following measures: HIV medical care visits, ART use, self-reported adherence, acute care utilization, viral load, and health-related quality of life

Secondary Outcomes

  • Intermediate outcome variables(Six month follow up)

Study Sites (1)

Loading locations...

Similar Trials